Previous 10 | Next 10 |
2024-03-09 04:50:41 ET Summary Health Catalyst reported strong Q4 results, meeting guidance and showing growth in technology and professional services revenue. The drop in HCAT's share price presents a buying opportunity, as the company's growth initiatives, such as its TEMS offer...
2024-03-02 11:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Health Catalyst Names UnityPoint Health Winner of the 2024 Flywheel Award PR Newswire SALT LAKE CITY , Feb. 27, 2024 /PRNewswire/ -- Today, Health Catalyst announced the winner of the 2024 Flywheel Award. The award recognizes healthcare organizations that have sh...
The 2024 Healthcare Analytics Summit (HAS) Kicks Off Today PR Newswire SALT LAKE CITY , Feb. 27, 2024 /PRNewswire/ -- Today, approximately 1,000 healthcare leaders from around the world have gathered in Salt Lake City to kick off the 2024 Healthcare Analytics...
2024-02-22 23:49:09 ET Health Catalyst, Inc. (HCAT) Q4 2023 Earnings Conference Call February 22, 2024 17:00 ET Company Participants Adam Brown - Senior Vice President, FP&A and Investor Relations Dan Burton - Chief Executive Officer Bryan Hunt - Chief Financ...
2024-02-22 16:38:41 ET More on Health Catalyst Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade) Health Catalyst Q4 2023 Earnings Preview Health Catalyst upgraded to buy at Guggenheim Seeking Alpha’s Quant Rating on Health C...
SOUTH JORDAN, Utah., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2023. ...
2024-02-21 15:26:22 ET More on Teladoc Health Teladoc Health: Another Bad Quarter, Another Wave Of Capitulation Teladoc: Should Investors Wait For Its Uncertain Turnaround Story? Teladoc Health, Inc. (TDOC) Q4 2023 Earnings Call Transcript Biggest stock mover...
Health Catalyst's Able Health Registry Receives CMS's QPP Qualified Registry Approval for 2024 PR Newswire SALT LAKE CITY , Feb. 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics techno...
Health Catalyst's MeasureAble™ Earns ONC Health IT Certification PR Newswire SALT LAKE CITY , Feb. 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthc...
News, Short Squeeze, Breakout and More Instantly...
2024-07-01 07:30:03 ET Wells Fargo analyst issues OVERWEIGHT recommendation for HCAT on July 1, 2024 06:12AM ET. The previous analyst recommendation was Overweight. HCAT was trading at $6.39 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-06-22 03:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive PR Newswire SALT LAKE CITY , June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services t...